Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Dodecanoate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.77 |
| ▸ | PPARG | P37231 | 7/20 | 0.77 |
| ▸ | PPARD | Q03181 | 7/20 | 0.77 |
| ▸ | PPARA | Q07869 | 7/20 | 0.77 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.77 |
| ▸ | TSHR | P16473 | 4/20 | 0.77 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.77 |
| ▸ | FABP4 | P15090 | 3/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.77 |
| ▸ | TLR2 | O60603 | 2/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.77 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.77 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.77 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.77 |
| ▸ | MEN1 | O00255 | 1/20 | 0.77 |
| ▸ | ESR1 | P03372 | 1/20 | 0.77 |
| ▸ | PDE4A | P27815 | 1/20 | 0.77 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Decanoic Acid SCHEMBL28234068 | 1.00 | GPR84 (0.77) | GPR84PPARGPPARDPPARAHDAC11 | |
| Palmitic Acid SCHEMBL28477534 | 1.00 | GPR84 (0.77) | GPR84PPARGPPARDPPARAHDAC11 | |
| Behenic Acid SCHEMBL27704978 | 1.00 | GPR84 (0.77) | GPR84PPARGPPARDPPARAHDAC11 | |
| Myristic Acid SCHEMBL27276583 | 1.00 | GPR84 (0.77) | GPR84PPARGPPARDPPARAHDAC11 | |
| Octanoic Acid SCHEMBL28722049 | 1.00 | GPR84 (0.77) | GPR84PPARGPPARDPPARAHDAC11 | |
| Tridecanoate SCHEMBL28675555 | 1.00 | GPR84 (0.77) | GPR84PPARGPPARDPPARAHDAC11 | |
| Stearic Acid SCHEMBL27505871 | 1.00 | GPR84 (0.77) | GPR84PPARGPPARDPPARAHDAC11 | |
| Undecanoate SCHEMBL28998397 | 1.00 | GPR84 (0.77) | GPR84PPARGPPARDPPARAHDAC11 | |
| Myristic Acid SCHEMBL4230923 | 1.00 | GPR84 (0.77) | GPR84PPARGPPARDPPARAHDAC11 | |
| Stearic Acid SCHEMBL4970044 | 0.98 | GPR84 (0.74) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 507 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12487224-B2 | Soil analysis compositions and methods | PRECISION PLANTING LLC (US) | 2025-12-02 | — | — | US | claimed |
| US-12352740-B2 | Soil analysis compositions and methods | PRECISION PLANTING LLC (US) | 2025-07-08 | — | — | US | claimed |
| EP-4182660-B1 | SOIL ANALYSIS COMPOSITIONS AND METHODS | PREC PLANTING LLC (US) | 2025-07-02 | — | — | EP | claimed |
| EP-4182659-B1 | SOIL ANALYSIS METHOD | PREC PLANTING LLC (US) | 2025-07-02 | — | — | EP | claimed |
| EP-4182669-B1 | SOIL ANALYSIS METHODS | PREC PLANTING LLC (US) | 2025-07-02 | — | — | EP | claimed |
| WO-2025051022-A1 | TECHNETIUM [99TC] METHYLENE DIPHOSPHONATE ORAL FORMULATION, PREPARATION METHOD THEREFOR, AND USE THEREOF | 成都云克药业有限责任公司 | 2025-03-13 | — | — | WO | claimed |
| CN-119264893-A | Medium-phase microemulsion, oil displacement method using medium-phase microemulsion and application of medium-phase microemulsion | 中国石油天然气股份有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-119111517-A | Air response type long-acting stable chlorine dioxide sustained-release tablet | 广西艾科宁消毒科技有限公司 | 2024-12-13 | — | — | CN | claimed |
| US-20240301326-A1 | CAGELESS SELF-ADHESIVE LAVATORY CLEANING COMPOSITION | Reckitt Benckiser Health Limited (GB) | 2024-09-12 | — | — | US | claimed |
| CN-118393828-A | Stripping composition of high heat resistance photoresist and application thereof | 上海飞凯材料科技股份有限公司 | 2024-07-26 | — | — | CN | claimed |
| US-20140194482-A1 | COMPOSITIONS AND METHODS OF TREATMENT OF INFLAMMATORY SKIN CONDITIONS USING ALLANTOIN | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2014-07-10 | — | — | US | claimed |
| US-20140121255-A1 | Methods of Treating Psoriasis Using Allantoin | SCIODERM, INC. (US) | 2014-05-01 | — | — | US | claimed |
| CN-103654632-A | surface cleaning device | BISSELL HOMECARE INC | 2014-03-26 | — | — | CN | claimed |
| CN-103666876-A | Vehicle cleaning fluid and preparation method thereof | NANTONG REPAIR AIR CHEM BIOENG | 2014-03-26 | — | — | CN | claimed |
| WO-2013182688-A1 | A TOPICAL GEL COMPOSITION COMPRISING AN INGENOL DERIVATIVE AND A SOLVENT MIXTURE | LEO LABORATORIES LIMITED (IE) | 2013-12-12 | — | — | WO | claimed |
| CN-102364616-A | Nanometer composite material Fe3O4@PS@Ag with core-shell structure and preparation method thereof | UNIV SOUTH CHINA NORMAL | 2012-02-29 | — | — | CN | claimed |
| WO-2008042557-A2 | FORMULATION AND METHOD FOR A SHAMPOO FOR ANIMALS | EPIDERMAPET, LLC (US) | 2008-04-10 | — | — | WO | claimed |
| US-20080081036-A1 | FORMULATION AND METHOD FOR A SHAMPOO FOR ANIMALS | EPIDERMA PET, LLC (US) | 2008-04-03 | — | — | US | claimed |
| CN-1256935-C | Aqueous pearlescent concentrate compositions comprising ethoxylated glycerides | KAO CORP (JP) | 2006-05-24 | — | — | CN | claimed |
| CN-1536985-A | Aqueous pearlescent concentrate compositions comprising ethoxylated glycerides | ������������ʽ���� | 2004-10-13 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140194482-A1 | COMPOSITIONS AND METHODS OF TREATMENT OF INFLAMMATORY SKIN CONDITIONS USING ALLANTOIN | CUTA, ITCH, ARG1 | GPR84 2725/4885PPARG 2191/4885PPARD 3317/4885 |
| US-20140121255-A1 | Methods of Treating Psoriasis Using Allantoin | CUTA, ITCH, PPIA | GPR84 3067/4885PPARG 2372/4885PPARD 3218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.